Authors: SCHMETTER BS HABICHT KK LAMM DL MORALES A BANDER NH GROSSMAN HB HANNA MG SILBERMAN SR BUTMAN BT

Citation: Bs. Schmetter et al., A MULTICENTER TRIAL EVALUATION OF THE FIBRIN FIBRINOGEN DEGRADATION PRODUCTS TEST FOR DETECTION AND MONITORING OF BLADDER-CANCER/, The Journal of urology, 158(3), 1997, pp. 801-805

Authors: REBECK GW YESS JP JEFFRIES EP SILBERMAN SR

Citation: Gw. Rebeck et al., CSF APO-E LEVELS IN ALZHEIMERS-DISEASE, Clinical chemistry, 43, 1997, pp. 691-691

Authors: SCHAEFER EJ ORDOVAS JM DELUCA C DAGOSTINO RB WOLF PA TADDEIPETERS W BUTMAN RJ SILBERMAN SR WILSON PWF

Citation: Ej. Schaefer et al., LIPOPROTEIN (A), CORONARY HEART-DISEASE, AND CAROTID-ARTERY ATHEROSCLEROSIS IN THE FRAMINGHAM HEART-STUDY, Clinical chemistry, 43, 1997, pp. 747-747

Authors: TADDEIPETERS WC MACOMBER PF PLANK MC BUTMAN BT RANSOM JH SILBERMAN SR

Citation: Wc. Taddeipeters et al., COMPARISON OF COMMERCIAL LP(A) IMMUNOASSAYS, Clinical chemistry, 42(6), 1996, pp. 797-797

Authors: SILBERMAN SR JEFFRIES E MACOMBER P BUTMAN BT BUTLER SM TADDEIPETERS WC

Citation: Sr. Silberman et al., CAN THE APO-TEK-APO-E(TM) ELISA TEST SYSTEM BE USED TO DETERMINE APO-E GENOTYPE, Clinical chemistry, 42(6), 1996, pp. 820-820